Thirty-seven patients (21 merle, 16 female, mean age 71 years) receive
d identical DDD pacemakers. They also received the same bipolar ventri
cular passive fixation electrode, which has a microporous tip of plati
num-iridium, a surface area of 5.8 mm(2), and steroid elution. Eightee
n months after implantation the ventricular charge threshold [mu C] wa
s measured telemetrically at 0.5, 1.0, and 2.0 V, respectively. For th
e 1.0 and 2.0 V amplitudes the pulse duration was increased until the
charge per pulse [mu C] was twice the threshold value, thus giving a 1
00% safety margin in terms of charge (''safety charge''). Patients who
had ventricular capture at 0.5 V were permanently programmed to 1.0 V
(30/37 patients), while those who did not capture at 0.5 V were set t
o 2.0 S' (7/37 patients). In both cases, the pulse duration was progra
mmed according to the rationale of ''safety charge.'' During a routine
follow-up period of 6 months, no complications were observed and none
of the patients suffered from symptoms indicating loss of ventricular
capture. Twenty-four-hour Holter recordings, obtained from all patien
ts at the end of the follow-up with the output parameters unchanged, r
evealed constant ventricular capture. In patients with chronic stable
pacing thresholds and steroid-eluting low threshold leads who have cap
ture at 0.5 V, chronic ventricular pacing at an output amplitude of 1.
0 V is feasible, and if seems to be safe if the pacing threshold is me
asured as charge delivered per pulse and a 100% safety margin in terms
of charge is programmed. Reducing the output amplitude to well below
the battery voltage may increase pacemaker longevity.